The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases

INTRODUCTION: Thromboembolic events (TEs) are associated with considerable costs. However, there is a paucity of evidence quantifying the economic burden associated with TEs among patients with immune-mediated diseases (IMDs). METHODS: This retrospective cohort study used the IBM MarketScan(®) Comme...

Descripción completa

Detalles Bibliográficos
Autores principales: Setyawan, Juliana, Billmyer, Emma, Mu, Fan, Yarur, Andres, Zichlin, Miriam L., Yang, Hongbo, Downes, Nathaniel, Azimi, Nassir, Strand, Vibeke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799558/
https://www.ncbi.nlm.nih.gov/pubmed/34905149
http://dx.doi.org/10.1007/s12325-021-02004-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799558/
https://www.ncbi.nlm.nih.gov/pubmed/34905149
http://dx.doi.org/10.1007/s12325-021-02004-1

Ejemplares similares